Published in Health and Medicine Week, November 24th, 2003
Worldwide sales of its Given Diagnostic System and M2A capsules reached $9.7 million in the third quarter of 2003, representing a 30% increase over sales in the third quarter of 2002.
Gross profit was 63.0% of revenues, compared to 58.7% in the third quarter of 2002. Net loss continued to decline to $2.1 million or $0.08 per share in the third quarter of 2003, compared to a net loss of $3.9 million or $0.16 per share in the third quarter of 2002. The cash burn rate declined to $1.4 million in the quarter compared to $7.8 million during the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week